WHITEPAPER - Container Closure Integrity Issues in Cell & Gene Therapy Products
The cell and gene therapy (CGT) product market is expected to grow at a very high rate of around 20-30% per year over the next 10 years. Increasing number of approvals, expansion of target diseases, accelerated investment and innovation, and advent of aging population are the key factors for the growth. Cell and gene therapy products (CGT) are “living drugs” and require much stricter ultra-low and cryogenic temperature control than the conventional drugs. In this white paper, you will learn how OXYCAPT, a multi-layer plastic vial made of cycloolefin polymer (COP) and high gas barrier polymer, possesses excellent characteristics of COP, such as low extractables, breakage resistance, and low protein adsorption, while the gas barrier polymer in the middle layer prevents the diffusion of carbon dioxide and the pH shift of CGT products.
Total Page Views: 13
